Aurubis stock posts 31 percent EBT growth after nine months

Aurubis stock (ISIN DE0006766504) was last at EUR 157.20 on Xetra on October 6, 2026 at 5:35 p.m. CEST, while nine-month operating EBT reached EUR 374 million, up 31 percent from EUR 286 million in the prior-year period. The result keeps the company on track for its fiscal-year outlook.

EBT growth strengthens the outlook

According to finanzen.net on October 2, 2026, operating EBT in the third quarter was EUR 149 million, compared with EUR 57 million in the year-earlier quarter. That quarterly increase of EUR 92 million explains why the nine-month figure advanced despite the stock trading below its recent peak.

The same report said Aurubis confirmed an operating EBT forecast of EUR 425 million to EUR 525 million for fiscal 2025/26. The fiscal year ended on September 30, 2026, making the December results release the next major test of how much of the range the company achieved.

Stock remains below its yearly high

Aurubis stock was last at EUR 157.20 on October 6, 2026, down 0.82 percent from the prior session on the Xetra quote cited in the market data. Its 52-week range was EUR 102.00 to EUR 225.20 as of October 4, 2026, leaving the share price EUR 68.00 below the high.

Market capitalization stood at EUR 6.8 billion on October 4, 2026. The contrast between the 31 percent EBT growth and the distance from the 52-week high puts execution and cash generation ahead of headline revenue growth for the next update.

December results set the next checkpoint

According to Simply Wall St, Aurubis is scheduled to report fiscal 2026 results on December 2, 2026. The companys investor-relations page places its shares in the Prime Standard segment and the MDAX, linking the upcoming report to a widely followed German mid-cap benchmark.

For investors, the central comparison is clear: operating EBT of EUR 374 million after nine months versus EUR 286 million a year earlier, against a stock price still below EUR 160. The December publication will show whether the final quarter converts that earnings progress into the upper half of the EUR 425 million to EUR 525 million range.

EUR 157.20 remains the reference level

Aurubis stock was last at EUR 157.20 on Xetra on October 6, 2026 at 5:35 p.m. CEST. The next dated company checkpoint is December 2, 2026.

Upcoming dates for Aurubis stock

• December 2, 2026: Fiscal 2026 results

More news and analysis on Aurubis stock